Dan Brounstein

Chief Strategy Officer, Saluda

Dan Brounstein, Chief Strategy Officer, has over 18 years’ experience in the medical device field holding senior roles in marketing, sales and engineering. Prior to joining Saluda, Mr. Brounstein held the position of Vice President Marketing and Clinical Operations at Spinal Modulation, where he most recently led US operations for their IDE pivotal study and directed the marketing and business strategy.